Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
After finishing at $19.72 in the prior trading day, Viridian Therapeutics Inc (NASDAQ: VRDN) closed at $19.53, down -0.96%. In other words, the price has decreased by -$0.96 from its previous closing price. On the day, 1.1 million shares were traded. VRDN stock price reached its highest trading level at $19.98 during the session, while it also had its lowest trading level at $19.398.
Ratios:
Our goal is to gain a better understanding of VRDN by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 18.55 and its Current Ratio is at 18.55. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.03.
On September 11, 2024, Needham reiterated its Buy rating and also lowered its target price recommendation from $30 to $38.
On June 11, 2024, Wolfe Research started tracking the stock assigning a Outperform rating and target price of $29.Wolfe Research initiated its Outperform rating on June 11, 2024, with a $29 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 27 ’24 when Beetham Thomas W. bought 5,000 shares for $23.41 per share. The transaction valued at 117,050 led to the insider holds 6,000 shares of the business.
Mahoney Stephen F. bought 21,400 shares of VRDN for $499,262 on Sep 27 ’24. The President and CEO now owns 21,400 shares after completing the transaction at $23.33 per share. On Sep 13 ’24, another insider, Fairmount Funds Management LLC, who serves as the Director of the company, bought 1,600,000 shares for $18.75 each. As a result, the insider paid 30,000,000 and bolstered with 3,445,813 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, VRDN now has a Market Capitalization of 1547024128 and an Enterprise Value of 1005943936. For the stock, the TTM Price-to-Sale (P/S) ratio is 5180.41 while its Price-to-Book (P/B) ratio in mrq is 2.98. Its current Enterprise Value per Revenue stands at 3330.94 whereas that against EBITDA is -3.561.
Stock Price History:
Over the past 52 weeks, VRDN has reached a high of $27.20, while it has fallen to a 52-week low of $11.40. The 50-Day Moving Average of the stock is -13.13%, while the 200-Day Moving Average is calculated to be 12.87%.
Shares Statistics:
The stock has traded on average 1.52M shares per day over the past 3-months and 904410 shares per day over the last 10 days, according to various share statistics. A total of 79.18M shares are outstanding, with a floating share count of 70.14M. Insiders hold about 11.45% of the company’s shares, while institutions hold 98.98% stake in the company. Shares short for VRDN as of 1731628800 were 9097352 with a Short Ratio of 6.00, compared to 1728950400 on 9791768. Therefore, it implies a Short% of Shares Outstanding of 9097352 and a Short% of Float of 13.04.
